FDA Approved: BEXAROTENE — Original Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Mylan's generic bexarotene for use in cutaneous T-cell lymphoma, including mycosis fungoides and Sézary syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma
• Mycosis Fungoides
• Sézary Syndrome

Drugs mentioned

• Bexarotene (Bexarotene)

Snippet

ORIG AP for BEXAROTENE (BEXAROTENE)